China Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The China Diabetes Drugs and Devices Market report is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood and continuous glucose monitoring)). The report offers the value (in USD) and volume (in units) for the above segments.

China Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

China Diabetes Drugs And Devices Market Size

China Diabetes Drugs And Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 20.35 Billion
Market Size (2030) USD 24.17 Billion
CAGR (2025 - 2030) 3.50 %

Major Players

China Diabetes Drugs And Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of China Diabetes Drugs And Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

China Diabetes Drugs And Devices Market Analysis

The China Diabetes Drugs And Devices Market size is estimated at USD 20.35 billion in 2025, and is expected to reach USD 24.17 billion by 2030, at a CAGR of greater than 3.5% during the forecast period (2025-2030).

Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased risk of serious disease and death. The current study suggests that COVID-19 individuals with diabetes require focused early intervention. According to Peking University (Beijing, China), research, intensive care unit (ICU) patients had an approximately threefold higher prevalence of diabetes than non-ICU patients. Various studies on the prevalence of diabetes have diverse results.

During the quarantine period, about 60% of persons with diabetes encountered food or medicine shortages, much greater than those without diabetes. Various studies on the prevalence of diabetes have diverse results. During the quarantine period, about 60% of persons with diabetes encountered food or medicine shortages, which was much more significant than those without diabetes. Notably, respondents who reported medication shortages had a 63% higher rate of COVID-19 infection.

Type 1 diabetes patients will account for more than 9.5% of China's overall diabetes population in the current year. Blood glucose swings among insulin users are common in China owing to lifestyle and eating habits, and self-monitoring of blood glucose fails to adequately reflect the blood glucose profile since it only shows the glucose concentration at a single time point.

China has the highest number of diagnosed and undiagnosed diabetes cases in the world, as per Diabetes Research and Clinical Practice. The number of diagnosed diabetics in China has increased by 56% from 2011 to 2021. Over 75% of adults with diabetes reside in low- and middle-income countries. Diabetes-related health expenditures have surged by 316% to USD 966 billion globally over the past 15 years, with China ranking second with USD 165.3 billion.

Thus, a trend in the demand for diabetes drugs in China has been noted. In the pharmaceutical sector, insulin has a substantial market share. Insulin is used by around 100 million individuals worldwide, including all Type 1 diabetes patients and 10% to 25% of Type 2 diabetic patients. Insulin production is exceedingly complex, with just a few insulin manufacturers on the market. As a result, there is tremendous competition among these companies, which always seek to meet patient requests by offering the highest-quality insulin.

Thus, the above factors are expected to drive market growth over the forecast period.

China Diabetes Drugs And Devices Industry Overview

Manufacturers have constantly innovated to survive in the market. Large companies such as Abbott and Medtronic have made numerous mergers, acquisitions, and partnerships to gain market dominance while adhering to organic growth strategies in the diabetes devices market. The market for diabetes drugs is fiercely competitive, as numerous prominent companies vie for a slice of the market. These companies prioritize the development of groundbreaking drugs and treatments to cater to the ever-changing requirements of diabetes patients. A handful of key players hold sway over the competitive landscape in this industry. To expand their market share, these players employ various strategies such as making investments, forming alliances, engaging in acquisitions, and pursuing mergers.

China Diabetes Drugs And Devices Market Leaders

  1. Medtronics

  2. Roche

  3. NovoNordisk

  4. Sanofi

  5. Omnipod

  6. *Disclaimer: Major Players sorted in no particular order
China Diabetes Drugs And Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

China Diabetes Drugs And Devices Market News

  • April 2023: The National Healthcare Security Administration announced that China's diabetes patients can now access high-quality and more affordable insulin products, as the country's drug bulk-buying program for insulin products led to an average price cut of 48%. The centralized procurement is estimated to save CNY 9 billion (about USD 1.31 billion) in diabetes-related health expenditures yearly.
  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics (DTT) has published Real World Evidence of Improved Glycemic Control in People with Diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter- synced via Bluetooth wireless technology could support improved glycemic control for people with diabetes.

China Diabetes Drugs And DevicesMarket Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Restraints
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products and Services
    • 4.3.5 Intensity of Competitive Rivalry

5. Market Segmentation (Market Size by Value - USD)

  • 5.1 Devices
    • 5.1.1 Monitoring Devices
    • 5.1.1.1 Self-monitoring Blood Glucose Devices
    • 5.1.1.2 Continuous Blood Glucose Monitoring
    • 5.1.2 Management Devices
    • 5.1.2.1 Insulin Pump
    • 5.1.2.2 Insulin Syringes
    • 5.1.2.3 Insulin Cartridges
    • 5.1.2.4 Disposable Pens
  • 5.2 Drugs
    • 5.2.1 Oral Anti-Diabetes Drugs
    • 5.2.2 Insulin Drugs
    • 5.2.3 Combination Drugs
    • 5.2.4 Non-Insulin Injectable Drugs

6. Market Indicators

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk
    • 7.1.2 Medtronic
    • 7.1.3 Insulet
    • 7.1.4 Tandem
    • 7.1.5 Ypsomed
    • 7.1.6 Novartis
    • 7.1.7 Sanofi
    • 7.1.8 Eli Lilly
    • 7.1.9 Abbottt
    • 7.1.10 Roche
    • 7.1.11 Astrazeneca
    • 7.1.12 Dexcom
    • 7.1.13 Pfizer
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Diabetes Drugs And Devices Industry Segmentation

Patients with type 1 diabetes must be given insulin because their pancreas cannot process it. To control blood sugar levels, insulin must be injected several times daily, such as when eating or drinking. Many people with type 2 diabetes also need to take antidiabetic drugs. These drugs include diabetes medications and injections such as insulin. The Chinese diabetes drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood and continuous glucose monitoring). The report offers value (in USD) and volume (in units) for the above segments.

Devices Monitoring Devices Self-monitoring Blood Glucose Devices
Continuous Blood Glucose Monitoring
Management Devices Insulin Pump
Insulin Syringes
Insulin Cartridges
Disposable Pens
Drugs Oral Anti-Diabetes Drugs
Insulin Drugs
Combination Drugs
Non-Insulin Injectable Drugs
Need A Different Region or Segment?
Customize Now

China Diabetes Drugs And DevicesMarket Research FAQs

How big is the China Diabetes Drugs And Devices Market?

The China Diabetes Drugs And Devices Market size is expected to reach USD 20.35 billion in 2025 and grow at a CAGR of greater than 3.5% to reach USD 24.17 billion by 2030.

What is the current China Diabetes Drugs And Devices Market size?

In 2025, the China Diabetes Drugs And Devices Market size is expected to reach USD 20.35 billion.

Who are the key players in China Diabetes Drugs And Devices Market?

Medtronics, Roche, NovoNordisk, Sanofi and Omnipod are the major companies operating in the China Diabetes Drugs And Devices Market.

What years does this China Diabetes Drugs And Devices Market cover, and what was the market size in 2024?

In 2024, the China Diabetes Drugs And Devices Market size was estimated at USD 19.64 billion. The report covers the China Diabetes Drugs And Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Diabetes Drugs And Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

China Diabetes Drugs And DevicesIndustry Report

Statistics for the 2025 China Diabetes Drugs And Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Diabetes Drugs And Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.